Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports the company's current earnings are A$32.57 Billion. In 2023 the company made an earning of A$9.57 Billion, an increase over its 2022 earnings that were of A$9.22 Billion. The earnings displayed on this page is the company's Pretax Income.